SpectraCure
Founded Year
2003About SpectraCure
SpectraCure develops a system for the treatment of cancer. It aims to eliminate internal cancer tumors and improve survival rates and quality of life. Its method is based on photodynamic therapy (PDT), which means that a light-activated drug is used to make the tissue sensitive to light. The drug is then activated by a laser, which eliminates the cancer cells. It was founded in 2003 and is based in Lund, Sweden.
Missing: SpectraCure's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: SpectraCure's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
SpectraCure Frequently Asked Questions (FAQ)
When was SpectraCure founded?
SpectraCure was founded in 2003.
Where is SpectraCure's headquarters?
SpectraCure's headquarters is located at Gasverksgatan 1, Lund.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.